Inscrição YC de Nomic Bio

Winter 2020Active

Nomic Bio passou pela Y Combinator no batch Winter 2020 como uma empresa Healthcare. Abaixo: o que a empresa faz, quem a fundou e sua inscrição para a YC, reconstruída pergunta por pergunta no formulário real da YC.

Batch YC: Winter 2020
Indústria: HealthcareDiagnostics
Tamanho da equipe: 24
Status: Active
Lançada: 2020

Fundadores

Milad DagherFounder
Jeff MunzarFounder

O que Nomic Bio faz

Nomic is doing for protein profiling, what Illumina did for DNA sequencing. Our core technology, the nELISA, is a next-gen immunoassay platform that transforms the ELISA into a high-throughput, high-content, and high-versatility tool. Today we developed the nELISA for high-throughput drug discovery scientists, enabling them profile 100s of proteins at 10x higher throughput and 10x lower cost compared to existing solutions. We're offering the nELISA through early access programs to HTS groups in top pharmas as well as pioneering biotechs in the space. Our goal is to create a ubiquitous technology that consolidates the broad range of legacy immunoassay toolkits that scientists use today with a single platform that can carry the science end-to-end, from discovery all the way to the clinic. We're a team of engineers, biologists, and highly-skilled lab operators that are looking to grow quickly to keep up with customer demand but also to continue developing our core technology, scale our multiplexing/throughput, and build our software stack. We're hiring on a number of positions including engineering, software, biology, and ops. Come talk to us!

Inscrição YC de Nomic Bio, reconstruída

Inscrição Y Combinator

Nomic Bio, lote Winter 2020. As verdadeiras perguntas do formulário, respondidas com dados públicos.

Founders2
Company7
Progress7
Idea4
Equity3
Curious2
Batch Preference1

Company

Company name

Nomic Bio

Describe what your company does in 50 characters or less.

Protein profiling like Illumina did for DNA

What is your company going to make? Please describe your product and what it does or will do.

We built the nELISA, a next-generation immunoassay platform that lets drug discovery scientists profile hundreds of proteins simultaneously with 10x higher throughput and 10x lower cost than current solutions. Unlike legacy ELISA kits, our platform scales high-content protein measurement for early discovery through to clinical use, consolidating multiple assay types into one versatile tool.

Where do you live now, and where would the company be based after YC?

We live in Montreal, QC, Canada, and plan to keep the company based here after YC.

Explain your decision regarding location.

Montreal has the local expertise in biochemistry, engineering, and nanotech that our platform requires. It also offers a strong, low-cost talent pool compared to typical US hubs and aligns with the founders' personal ties and initial lab setup.

21 respostas a mais na inscrição completa

Founders, Progress, Idea, Equity, Curious, Batch Preference estão na versão completa. Crie uma conta gratuita para abri-la no YC Insights, ao lado de todos os outros batches da YC.

Ver inscrição completa

Perguntas Frequentes

Esta é a inscrição real da YC de Nomic Bio?

Não. A Y Combinator mantém as inscrições submetidas em privado. Esta é uma reconstrução: as perguntas reais do formulário da YC, respondidas a partir dos dados públicos de Nomic Bio (notas de lançamento, históricos de fundadores, descrição do produto). Mostra como uma empresa como Nomic Bio se apresentaria à YC, não o texto que eles submeteram.

Em qual batch da YC Nomic Bio esteve?

Nomic Bio fez parte do batch Winter 2020 da Y Combinator.

Quem fundou o Nomic Bio?

O Nomic Bio foi fundado por Milad Dagher, Jeff Munzar.

O que o Nomic Bio faz?

Nomic is doing for proteins what Illumina has done for DNA

Como eu leio o application completo reconstruído?

Crie uma conta gratuita no Round Funded. A versão completa de 26 respostas do application do Nomic Bio, e de todos os outros lotes do YC, está no YC Insights.